Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells

Molecular Endocrinology

Volumn 17, Issue 9, 2003, Pages 1726-1737

  Wright, Michael E ^a   Tsai, Ming Jer ^b   Aebersold, Ruedi ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BETA TUBULIN; CYTOSKELETON PROTEIN; ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN;

ANDROGEN THERAPY; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; CARCINOMA; CELL DIFFERENTIATION; GENE SILENCING; HUMANS; MALE; NEUROSECRETORY SYSTEMS; PHENOTYPE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 0041833727     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0031     Document Type: Article

References (44)

1. Balk SP 2002 Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132-138; discussion, 138-139
2. Prins GS 2000 Molecular biology of the androgen receptor. Mayo Clin Proc 75(Suppl):S32-S35
3. Walsh PC 1980 Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am 7:583-591
4. Huggins C, Hodges CV 1972 Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22:232-240
5. Navarro D, Luzardo O, Fernandez L, Chesa N, Diaz-Chico B 2002 Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 81:191-201
6. Isaacs JT, Lundmo PI, Berges R, Martikainen P, Kyprianou N, English HF 1992 Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl 13:457-464
7. Craft N, Chhor C, Tran C, Belldegrun A, DeKernion J, Witte ON, Said J, Reiter RE, Sawyers CL 1999 Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res 59:5030-5036
8. Klotz L 2000 Hormone therapy for patients with prostate carcinoma. Cancer 88:3009-3014
9. Debes J, Tindall D 2002 The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187:1-7
10. Abrahamsson PA, Lilja H 1989 Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland. Prostate 14:71-81
11. Guate JL, Escaf S, Menendez CL, del Valle M, Vega JA 1997 Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment. Urol Int 59:149-153
12. Abrahamsson PA 1999 Neuroendocrine differentiation in prostatic carcinoma. Prostate 39:135-148
13. van Steenbrugge GJ, van Uffelen CJ, Bolt J, Schroder FH 1991 The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J Steroid Biochem Mol Biol 40:207-214
14. Burchardt T, Burchardt M, Chen MW, Cao Y, de la Taille A, Shabsigh A, Hayek O, Dorai T, Buttyan R 1999 Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol 162:1800-1805
15. Kokontis JM, Hay N, Liao S 1998 Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 12:941-953
16. Lu S, Tsai SY, Tsai MJ 1999 Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Endocrinology 140:5054-5059
17. Saffran DC, Reiter RE, Jakobovits A, Witte ON 1999 Target antigens for prostate cancer immunotherapy. Cancer Metastasis Rev 18:437-449
18. Gelmann EP 2002 Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
19. Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H 2000 inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther 7:997-1007
20. Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA 2002 Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum Mol Genet 11:175-184
21. Montgomery MK, Xu S, Fire A 1998 RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 95:15502-15507
22. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T 2001 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
23. Kemppainen JA, Lane MV, Sar M, Wilson EM 1992 Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968-974
24. Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, Lin MF 2001 Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 1539:28-43
25. Balk SP, Ko YJ, Bubley GJ 2003 Biology of prostate-specific antigen. J Clin Oncol 21:383-391
26. Lindzey J, Kumar MV, Grossman M, Young C, Tindall DJ 1994 Molecular mechanisms of androgen action. Vitam Horm 49:383-432
27. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV 2001 Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15:1817-1828
28. Liu QY, Rubin MA, Omene C, Lederman S, Stein CA 1998 Fas ligand is constitutively secreted by prostate cancer cells in vitro. Clin Cancer Res 4:1803-1811
29. Eng LF 1985 Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8:203-214
30. Frederiksen K, McKay RD 1988 Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J Neurosci 8:1144-1151
31. Lendahl U, Zimmerman LB, McKay RD 1990 CNS stem cells express a new class of intermediate filament protein. Cell 60:585-595
32. Zimmerman L, Parr B, Lendahl U, Cunningham M, McKay R, Gavin B, Mann J, Vassileva G, McMahon A 1994 Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12:11-24
33. Eder IE, Culig Z, Putz T, Nessler-Menardi C, Bartsch G, Klocker H 2001 Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol 40:241-251
34. Abate-Shen C, Shen MM 2000 Molecular genetics of prostate cancer. Genes Dev 14:2410-2434
35. Jongsma J, Oomen MH, Noordzij MA, Romijn JC, van Der Kwast TH, Schroder FH, van Steenbrugge GJ 2000 Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate 42:34-44
36. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ 2002 Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62:1008-1013
37. Webber MM, Bello D, Quader S 1997 Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. II. Tumorigenic cell lines. Prostate 30:58-64
38. Chlenski A, Nakashiro K, Ketels KV, Korovaitseva GI, Oyasu R 2001 Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate 47:66-75
39. Gregory CW, Johnson Jr RT, Mohler JL, French FS, Wilson EM 2001 Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res 61:2892-2898
40. Lendahl U, McKay RD 1990 The use of cell lines in neurobiology. Trends Neurosci 13:132-137
41. Donahue LM, Coates PW, Reinhart AJ 1996 Characterization of developmental stage and neuronal potential of the rat PNS-derived stem cell line, RT4-AC. Brain Res Dev Brain Res 94:67-80
42. Zhang L, Chang YH, Barker JL, Hu Q, Maric D, Li BS, Rubinow DR 2000 Testosterone and estrogen affect neuronal differentiation but not proliferation in early embryonic cortex of the rat: the possible roles of androgen and estrogen receptors. Neurosci Lett 281:57-60
43. Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE 1994 Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 4:259-275
44. Freshney RI 2000 Culture of animal cells: a manual of basic technique. New York: Wiley; xxvi, 577